Nicholas Partners Small Cap Gr Instl holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
Nicholas Partners Small Cap Growth Fund Institutional Shares NPSGX
- NAV / 1-Day Return 19.75 / +1.02 %
- Total Assets 152.8M
-
Adj. Expense Ratio
0.990%
- Expense Ratio 0.990%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.00
- Turnover 147%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:06 AM GMT+0
Morningstar’s Analysis NPSGX
Will NPSGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Revolution Medicines Inc Ordinary Shares | 4.01 | 6M | Healthcare |
Enliven Therapeutics Inc | 3.14 | 5M | Healthcare |
BWX Technologies Inc | 2.99 | 5M | Industrials |
TFI International Inc | 2.90 | 5M | Industrials |
Callaway Golf Co | 2.74 | 4M | Consumer Cyclical |
Par Pacific Holdings Inc | 2.42 | 4M | Energy |
The Chefs' Warehouse Inc | 2.38 | 4M | Consumer Defensive |
Dianthus Therapeutics Inc | 2.26 | 4M | Healthcare |
Once Upon a Farm PBC | 2.23 | 4M | Consumer Defensive |
Xenon Pharmaceuticals Inc | 2.22 | 3M | Healthcare |